Search results
In 2013, Alessandro worked five months as pre-doctoral Visiting Fellow at the Westfålische Wilhelms-Universitåt in Münster (Germany), under the guidance of Prof. Bernhard Wünsch and Dr. Dirk Schepmann, where he tested novel series of ligands for PCP-binding site of NMDA receptor, σ1, σ2 and opioid receptor subtypes.
Alessandro Bonifazi. Highly Selective Dopamine D 3 Receptor (D 3 R) Antagonists and Partial Agonists Based on Eticlopride and the D 3 R Crystal Structure: New Leads for Opioid …. V Kumar, A Bonifazi, MP Ellenberger, TM Keck, E Pommier, R Rais, ... M Sánchez-Soto, A Bonifazi, NS Cai, MP Ellenberger, AH Newman, ...
Alessandro Bonifazi Carlo Cifani The enantiomers of the potent σ1 receptor antagonist (±)-1 were synthesized and evaluated for their affinity at σ1, σ2 receptors and dopamine transporter (DAT).
Aug 10, 2023 · Alessandro Bonifazi 1 , Elizabeth Saab 1 , Julie Sanchez 2 3 , Antonina L Nazarova 4 , Saheem A Zaidi 4 , Khorshada Jahan 1 , Vsevolod Katritch 4 , Meritxell Canals 2 3 , J Robert Lane 2 3 , Amy Hauck Newman 1
Alessandro Bonifazi, PhD. Associate Professor, Pharmacology & Toxicology; Email albonifa utmb edu; Overview; Similar Profiles (1) Powered by Pure, Scopus & Elsevier ...
Oct 2, 2015 · Alessandro Bonifazi Handle the sales and the customer needs, handle scientific meeting and handle pubblic tenders. Forlì . 20 others named Alessandro Bonifazi are on LinkedIn ...
- The University of Texas Medical Branch
Alessandro Bonifazi, Amy H. Newman, Thomas M. Keck, Silvia Gervasoni, Giulio Vistoli, Fabio Del Bello, Gianfabio Giorgioni, Pegi Pavletić, Wilma Quaglia, Alessandro Piergentili. Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders.
